Equally aligned with previous results, BiP expression was found to be higher in metastatic tumors, with its nuclear expression being associated with higher a tumor stage and poorer outcome, further suggesting, that BiP could be a prognostic indicator for breast cancer. This evidence concerns the gene HSPA5 and breast cancer.